Cargando…
Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study
Background and Objectives: The revascularization strategy for percutaneous coronary intervention (PCI) in patients with multivessel (MV) acute coronary syndrome (ACS) remains controversial. Certain gaps in the evidence are related to the optimal timing of non-culprit lesion revascularization and the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967361/ https://www.ncbi.nlm.nih.gov/pubmed/36837471 http://dx.doi.org/10.3390/medicina59020270 |
_version_ | 1784897245315858432 |
---|---|
author | Vasiljevs, Deniss Kakurina, Natalja Pontaga, Natalja Kokina, Baiba Osipovs, Vladimirs Sorokins, Nikolajs Pikta, Sergejs Trusinskis, Karlis Lejnieks, Aivars |
author_facet | Vasiljevs, Deniss Kakurina, Natalja Pontaga, Natalja Kokina, Baiba Osipovs, Vladimirs Sorokins, Nikolajs Pikta, Sergejs Trusinskis, Karlis Lejnieks, Aivars |
author_sort | Vasiljevs, Deniss |
collection | PubMed |
description | Background and Objectives: The revascularization strategy for percutaneous coronary intervention (PCI) in patients with multivessel (MV) acute coronary syndrome (ACS) remains controversial. Certain gaps in the evidence are related to the optimal timing of non-culprit lesion revascularization and the utility of instantaneous wave-free ratio (iFR) in the management of MV ACS intervention. The major benefits of iFR utilization in MV ACS patients in one-stage complete revascularization are: (1) the possibility to virtually plan the PCI, both the location and the extension of the necessary stenting to achieve the prespecified final hemodynamic result; (2) the opportunity to validate the final hemodynamic result of the PCI, both in culprit artery and all non-culprit arteries and (3) the value of obliviating the uncomfortable, costly, time consuming and sometimes deleterious effects from Adenosine, as there is no requirement for administration. Thus, iFR use fosters the achievement of physiologically appropriate complete revascularization in MV ACS patients during acute hospitalization. Materials and Methods: This pilot study was aimed to test the feasibility of a randomized trial research protocol as well as to assess patient safety signals of co-registration iFR-guided one-stage complete revascularization compared with that of standard staged angiography-guided PCI in de novo patients with MV ACS. This was a single-center, prospective, randomized, open-label clinical trial consecutively screening patients with ACS for MV disease. The intervention strategy of interest was iFR-guided physiologically complete one-stage revascularization, in which the virtual PCI planning of non-culprit lesions and the intervention itself were performed in one stage directly following treatment of the culprit lesion and other critical stenosis of more than ninety percent. Seventeen patients were recruited and completed the 3-month follow-up. Results: Index PCI duration was significantly longer while the volume of contrast media delivered in index PCI was significantly greater in the iFR-guided group than in the angiography-guided group (119.4 ± 40.7 vs. 47 ± 15.5 min, p = 0.004; and 360 ± 97.9 vs. 192.5 ± 52.8 mL, p = 0.003). There were no significant differences in PCI-related major adverse cardiovascular events (MACE) between the groups during acute hospitalization and at 3-months follow-up. One-stage iFR-guided PCI requires fewer PCI attempts until complete revascularization than does angiography-guided staged PCI. Conclusions: Complete revascularization with the routine use of the virtual planning tool in one-stage iFR-guided PCI is a feasible practical strategy in an everyday Cath lab environment following the protocol designed for the study. No statistically significant safety signals were documented in the number of PCI related MACE during the 3-month follow-up. |
format | Online Article Text |
id | pubmed-9967361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99673612023-02-26 Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study Vasiljevs, Deniss Kakurina, Natalja Pontaga, Natalja Kokina, Baiba Osipovs, Vladimirs Sorokins, Nikolajs Pikta, Sergejs Trusinskis, Karlis Lejnieks, Aivars Medicina (Kaunas) Article Background and Objectives: The revascularization strategy for percutaneous coronary intervention (PCI) in patients with multivessel (MV) acute coronary syndrome (ACS) remains controversial. Certain gaps in the evidence are related to the optimal timing of non-culprit lesion revascularization and the utility of instantaneous wave-free ratio (iFR) in the management of MV ACS intervention. The major benefits of iFR utilization in MV ACS patients in one-stage complete revascularization are: (1) the possibility to virtually plan the PCI, both the location and the extension of the necessary stenting to achieve the prespecified final hemodynamic result; (2) the opportunity to validate the final hemodynamic result of the PCI, both in culprit artery and all non-culprit arteries and (3) the value of obliviating the uncomfortable, costly, time consuming and sometimes deleterious effects from Adenosine, as there is no requirement for administration. Thus, iFR use fosters the achievement of physiologically appropriate complete revascularization in MV ACS patients during acute hospitalization. Materials and Methods: This pilot study was aimed to test the feasibility of a randomized trial research protocol as well as to assess patient safety signals of co-registration iFR-guided one-stage complete revascularization compared with that of standard staged angiography-guided PCI in de novo patients with MV ACS. This was a single-center, prospective, randomized, open-label clinical trial consecutively screening patients with ACS for MV disease. The intervention strategy of interest was iFR-guided physiologically complete one-stage revascularization, in which the virtual PCI planning of non-culprit lesions and the intervention itself were performed in one stage directly following treatment of the culprit lesion and other critical stenosis of more than ninety percent. Seventeen patients were recruited and completed the 3-month follow-up. Results: Index PCI duration was significantly longer while the volume of contrast media delivered in index PCI was significantly greater in the iFR-guided group than in the angiography-guided group (119.4 ± 40.7 vs. 47 ± 15.5 min, p = 0.004; and 360 ± 97.9 vs. 192.5 ± 52.8 mL, p = 0.003). There were no significant differences in PCI-related major adverse cardiovascular events (MACE) between the groups during acute hospitalization and at 3-months follow-up. One-stage iFR-guided PCI requires fewer PCI attempts until complete revascularization than does angiography-guided staged PCI. Conclusions: Complete revascularization with the routine use of the virtual planning tool in one-stage iFR-guided PCI is a feasible practical strategy in an everyday Cath lab environment following the protocol designed for the study. No statistically significant safety signals were documented in the number of PCI related MACE during the 3-month follow-up. MDPI 2023-01-31 /pmc/articles/PMC9967361/ /pubmed/36837471 http://dx.doi.org/10.3390/medicina59020270 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vasiljevs, Deniss Kakurina, Natalja Pontaga, Natalja Kokina, Baiba Osipovs, Vladimirs Sorokins, Nikolajs Pikta, Sergejs Trusinskis, Karlis Lejnieks, Aivars Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study |
title | Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study |
title_full | Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study |
title_fullStr | Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study |
title_full_unstemmed | Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study |
title_short | Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study |
title_sort | culprit versus complete revascularization during the initial intervention in patients with acute coronary syndrome using a virtual treatment planning tool: results of a single-center pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967361/ https://www.ncbi.nlm.nih.gov/pubmed/36837471 http://dx.doi.org/10.3390/medicina59020270 |
work_keys_str_mv | AT vasiljevsdeniss culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT kakurinanatalja culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT pontaganatalja culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT kokinabaiba culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT osipovsvladimirs culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT sorokinsnikolajs culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT piktasergejs culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT trusinskiskarlis culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy AT lejnieksaivars culpritversuscompleterevascularizationduringtheinitialinterventioninpatientswithacutecoronarysyndromeusingavirtualtreatmentplanningtoolresultsofasinglecenterpilotstudy |